Dr. Ermias Tilahun

Ermias Tilahun (MPH, Ph.D.) has over 10 years of professional work experience. He has had a unique opportunity to work in academia, in a clinical healthcare setting, a non-profit organization, and the pharmaceutical industry. Ermias is currently working at Pfizer in Medical Affairs Department with the Prevnar13 team where he serves as a junior scientist. He is responsible for conducting research on Invasive Pneumococcal Disease (IPD) as well as overseeing global IPD database and conducting post-approval/marketing research. In this role, he conducted a research on burden of Invasive Pneumococcal Disease in the US; he updated the global IPD repository database containing IPD serotype distributions causing pneumonia in children and adult; he conducted a systematic literature review on several topics; he has been also supporting Prevnar13 research group in strengthening disease surveillance system of countries around the globe.

Prior to joining Pfizer, Ermias was working as a Monitoring and Evaluation Advisor in an international non-profit organization called Management Science for Health (MSH). His strong public health educational background and extensive global public health experience, including in the area of pharmaceutical Science emanated from being part of public health schools, short and long term public health courses he attended in Ethiopian, Europe, and in the US. He had also worked as a research assistant and Graduate Teaching Assistant at Howard University, pharmaceutical science department. In this department along with his academic advisors as a graduate research assistant in the drug design and development lab and clinical pharmacy administration department, he has co-authored more than ten peer-reviewed publications. Ermias attended his Bachelor and Master’s Degree in public health. Ermias completed his Ph.D. in Pharmacoepidemiology at Howard University where he developed an innovative technology assisted tool to educate Medicare beneficiaries in the US about Pharmacist-Provided Medication Therapy Management Service (PP-MTM) as his dissertation study. He had also been a recipient of the top merit-based full scholarships offered at his department for four consecutive years.